Navigation Links
Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders
Date:12/8/2007

diopathic DVT. It has already been determined that the optimal duration of OAT for DVT can be tailored according to the presence of residual vein thrombosis (RVT), long-lasting blood clots that remain inside the vein, as RVT serves as a marker to assess the individual risk for recurrent thrombosis. However, in patients with idiopathic DVT who have not demonstrated RVT, the safety of early interruption of OAT is still debated. This prospective controlled study evaluated the safety of withholding OAT in patients with idiopathic DVT and without RVT, three months after the index thrombotic episode. The study evaluated two groups: DVT patients without RVT who stopped OAT after three months and those with RVT who continued OAT for an additional three months. During the period from 1999-2006, 518 patients were included in the study. In 206 patients (39.7 percent), RVT was considered absent (RVT negative group) and OAT was stopped; the remaining 312 patients continued receiving anticoagulants for an additional three months (RVT positive group). The study found that in patients without RVT, three months of OAT was safe even after an episode of idiopathic DVT. This indicates that individual markers for VT, such RVT, may help in the management of VT and can allow OAT duration to be tailored. The RVT finding applies to at least 30 percent of the entire DVT population and has an important clinical impact, indicating that patients at low risk of recurrent thrombosis can now safely withdraw from OAT after three months. This approach also carries a negligible risk for bleeding.

The study authors and press program moderator will be available for interviews after the press program or by telephone. In addition to blood clotting and bleeding disorders, additional press briefings will take place focusing on leukemias, sickle cell disease and thalassemia, hematologic malignancies, and transplantation. For the complete annual meeting schedule and additional information, please vi
'/>"/>

SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Sculpted Contours ... of Atlanta’s Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. ... the business as well as Kathy King. Her idea and vision to bring ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... a wealth of information for specific translation services within the medical and pharmaceutical ... incredible track record of successful work. , ITC Global Translations specializes in professional ...
(Date:8/31/2015)... Santa Rosa Beach, FL (PRWEB) , ... August 31, 2015 , ... ... Southern family of companies – has teamed up with fellow South Walton property ... organization focused on eliminating extreme poverty in remote parts of the world. The two ...
(Date:8/31/2015)... ... ... In an article based on a reader’s question that was ... treating back pain caused by a disrupted disk by using steroids rather than back ... in patients suffering from a herniated disk, the level of pain that patients experienced ...
(Date:8/31/2015)... ... August 31, 2015 , ... Wound Care Advantage, a leader ... Introduction to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to Hyperbaric ... in Long Beach, CA. The meeting is open for registration from physicians, clinicians ...
Breaking Medicine News(10 mins):Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4
... , ... ... ... ...
... antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality ... of 642 patients co-infected with HIV and tuberculosis. The ... TB and HIV services, lays to rest the controversy ... after TB treatment. Findings are published in the February ...
... a German neurologist have recently shown that the brain that ... from the part used when a verb is learnt. The ... resonance, according to an article they have published this month ... the left fusiform gyrus, while learning verbs switches on other ...
... passed anytime soon , THURSDAY, Feb. 25 (HealthDay News) ... Barack Obama on Thursday will hold a bipartisan summit ... tune in to watch is whether anything will come ... start from scratch and some Democrats conceding that passing ...
... ... Release of Their New Inguinal Hernia Product Range Freedom-I, with an Aim to Improve Surgical ... ... Medical is highly focused on bringing innovations to the field of medical devices. For the ...
... ... is extending its reach to provide expanded resources, seminars, presentations and E-learning opportunities in ... Belleville, ... individuals on skin integrity, seating and positioning, as well as wheelchair cushion and medical ...
Cached Medicine News:Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 2Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 3Health News:Combined drug therapy to treat TB and HIV significantly improves survival 2Health News:Nouns and verbs are learned in different parts of the brain 2Health News:Nouns and verbs are learned in different parts of the brain 3Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 2Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 3Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 4Health News:Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range 2Health News:Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range 3Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 2Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 3Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 4
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3
... KeraCel Ophthalmic Products are ... formulation of lint-free MEROCEL polyvinyl ... configured to be beneficial to ... being absorbent, and yet firm ...
... Products provide the surgeon ... products for unparalleled fluid ... of fine microsurgical instruments. ... is highly absorbent, fast ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: